De novo hepatocellular carcinoma in a liver graft with sustained hepatitis C virus clearance after living donor liver transplantation
Kazutoyo Morita(Kyushu University), Yoshihiko Maehara(Kyushu University), Shigeyuki Nagata(Kyushu University), Yuji Soejima(Shinshu University), Takasuke Fukuhara(Hokkaido University), Toru Ikegami(Jikei University School of Medicine), K Sugimachi(National Hospital Organization Kyushu Cancer Center), Tomohiro Iguchi(Fukuoka Higashi Medical Center), Tomonobu Gion(Kyushu University), Akinobu Taketomi(Hokkaido University), Ken Shirabe(Gunma University)
Cited by 31
Related Papers
Interleukin‐6/<scp>STAT</scp>3 signaling as a promising target to improve the efficacy of cancer immunotherapy
|Cancer Science|2017|295
Genome-wide Association Study Identifies TNFSF15 and POU2AF1 as Susceptibility Loci for Primary Biliary Cirrhosis in the Japanese Population
|The American Journal of Human Genetics|2012|272
Long‐term and perioperative outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma with propensity score matching: a multi‐institutional Japanese study
|Journal of Hepato-Biliary-Pancreatic Sciences|2015|267
Randomized phase <scp>III</scp> study of gemcitabine, cisplatin plus S‐1 versus gemcitabine, cisplatin for advanced biliary tract cancer (<scp>KHBO1401</scp>‐ <scp>MITSUBA</scp>)
|Journal of Hepato-Biliary-Pancreatic Sciences|2022|244